Eswarappa Mahesh, Reddy Sujeeth Bande, John Manns Manohar, Suryadevara Sarita, Madhyashatha Rakesh Parampalli
Department of Nephrology, Ramaiah Medical College and Hospitals, Bengaluru, Karnataka, India.
Saudi J Kidney Dis Transpl. 2019 Mar-Apr;30(2):394-400. doi: 10.4103/1319-2442.256847.
Dengue-related renal manifestations such as proteinuria, hematuria in the absence of thrombocytopenia, rhabdomyolysis, and acute kidney injury (AKI) are not uncommon. There is relatively sparse data on the renal manifestations of dengue viral infection (DVI). Hence, a retrospective study was conducted to investigate the incidence, characteristics, and clinical outcome of DVI with renal manifestations. A total of 2416 patients were admitted to our hospital with the diagnosis of dengue fever during the study period from 2012 to 2015. Data were collected from the electronic medical records and were analyzed retrospectively. The disease severity was classified according to the World Health Organization criteria. The renal manifestations were divided into AKI and non-AKI groups using AKI Network (AKIN) criteria. Proteinuria was defined as urinary protein >1+ (30 mg/dL) by dipstick test. A total of 218 patients were found to have proteinuria (9.56%). Most of the patients [135 (58.44%) with renal manifestations] were aged between 15 and 30 years. Comorbid conditions including diabetes mellitus, hypertension, and ischemic heart disease were seen in 10 (4.31%), 11 (4.76%), and six (2.59%) patients, respectively. Nephrotic-range proteinuria was seen in five patients (2.16%). AKI was seen in 82 patients (3.4%); 58 (70.73%) had AKIN-I, 19 (23.17%) had AKIN-II, and five patients (6.09%) had AKIN-III. Death occurred in 11 patients (39.28%) with AKI. The incidence of renal manifestations (proteinuria, hematuria, and AKI) is high at 9.59% among patients with dengue, and those with AKI had significant morbidity, mortality, longer hospital stay, and poor renal outcomes. Our findings suggest that AKI in dengue is likely to increase health-care burden that underscores the need for clinician's alertness to this highly morbid and potentially fatal complication for optimal prevention and management.
登革热相关的肾脏表现,如蛋白尿、无血小板减少情况下的血尿、横纹肌溶解和急性肾损伤(AKI)并不少见。关于登革热病毒感染(DVI)的肾脏表现的数据相对较少。因此,进行了一项回顾性研究,以调查有肾脏表现的DVI的发病率、特征和临床结局。在2012年至2015年的研究期间,共有2416例诊断为登革热的患者入住我院。数据从电子病历中收集并进行回顾性分析。疾病严重程度根据世界卫生组织标准分类。使用急性肾损伤网络(AKIN)标准将肾脏表现分为AKI组和非AKI组。蛋白尿定义为尿试纸检测尿蛋白>1+(30mg/dL)。共发现218例患者有蛋白尿(9.56%)。大多数患者[135例(58.44%)有肾脏表现]年龄在15至30岁之间。分别有10例(